Media Release as of 10:00am today"Auckland-based soft tissue...

Media Release as of 10:00am today

"Auckland-based soft tissue regeneration company, Aroa Biosurgery Limited, (ASX:ARX, ‘Aroa’ or the ‘Company’) expects to
continue to manufacture and ship its soft tissue regeneration products with no disruption, following the decision by the NZ
Government to move Auckland City to ‘Level 3’ COVID-19 prevention measures from midday today NZ time (10.00am AEST).
The NZ Government has advised the Level 3 measures will be in place for an initial period of three days, pending an assessment
of the degree of possible community transmission of COVID-19, following the discovery of four cases in Auckland yesterday.
Aroa is categorised as an “essential business” as it manufactures and sells medical devices. The Company continued to operate
effectively during March and April this year, under more arduous and restrictive lockdown criteria (Level 4).
The Company is well equipped to continue manufacturing and shipping to export markets, with nil or minimal disruption to
either in-bound or out-bound supply chains".